Table 1.
Baseline characteristics
| Characteristics | Mean ± SD N. percentage |
|---|---|
| Age (years), mean ± SD | 58.6 ± 14.7 |
| Gender (male/female), % | 64.7/32.3 |
| Years of education, mean ± SD | 8.9 ± 1.2 |
| DM, n (%) | 16 (23.5) |
| Arteriovenous fistulae, n (%) | 59 (86.8) |
| History of CVD, n (%) | 34 (50) |
| Dialysis vintage (months), median (IQR) | 46.5 (24–104) |
| RRF, n (%)a | 18 (26.5) |
| OL-HDF, n (%) | 50 (73.5) |
| Patients on antihypertensive drugs, n (%) | 43 (63.2) |
| Number of antihypertensive drugs, mean ± SD | 0.6 ± 0.4 |
| RAS inhibitors, n (%) | 18 (26.5) |
| β-blockers, n (%) | 24 (35.3) |
| Diuretics, n (%) | 8 (11.8) |
| Non-dihydropyridine calcium channel blocker, n (%) | 23 (33.8) |
| BMI (kg/m2) mean ± SD | 24.9 ± 6.4 |
| C-reactive protein (mg/dL), mean ± SD | 0.8 ± 1.4 |
| Serum albumin (g/dL), mean ± SD | 3.7 ± 0.4 |
| HDL cholesterol (mg/dL), mean ± SD | 46.2 ± 15.8 |
a
RRF defined as diuresis >500 mL/24 h.
RAS, renin–angiotensin system; BMI, body mass index; HDL, high-density lipoprotein.